These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 5818720)

  • 1. Parkinson's disease and amantadine hydrochloride.
    JAMA; 1969 May; 208(7):1180-1. PubMed ID: 5818720
    [No Abstract]   [Full Text] [Related]  

  • 2. Amantadine in the treatment of Parkinson's disease.
    Schwab RS; England AC; Poskanzer DC; Young RR
    JAMA; 1969 May; 208(7):1168-70. PubMed ID: 5818715
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of Parkinson's disease with amantadine].
    Sigwald J; Raymondeaud C; Grégoire J
    Therapeutique; 1972 Nov; 48(9):555-60. PubMed ID: 4568230
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
    Hacohen H; Gurtner B
    Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Parkinson's disease with amantadine and L-Dopa.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618
    [No Abstract]   [Full Text] [Related]  

  • 6. Amantadine in Parkinson's disease.
    Lancet; 1969 Aug; 2(7616):364. PubMed ID: 4183981
    [No Abstract]   [Full Text] [Related]  

  • 7. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS; England AC
    Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
    [No Abstract]   [Full Text] [Related]  

  • 8. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
    [No Abstract]   [Full Text] [Related]  

  • 9. [Amantadine hydrochloride in the treatment of Parkinson's syndrome].
    De la Herrán J; Figuerido JA
    Rev Esp Otoneurooftalmol Neurocir; 1971; 29(167):45-9. PubMed ID: 5091472
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of amantadine, placebo, and levodopa in Parkinson's disease.
    Bauer RB; McHenry JT
    Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination of amantadine and levodopa in the treatment of Parkinson's disease. Indications. Results. Study of 58 cases].
    Sigwald J; Raymondeaud C
    Nouv Presse Med; 1972 Apr; 1(18):1237-9. PubMed ID: 5025538
    [No Abstract]   [Full Text] [Related]  

  • 12. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S; Nagaswami R
    Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of amantadine therapy for parkinsonism and the side effects--in cases of thalamic surgery and L-dopa therapy.
    Matsumoto K; Omoto T; Beck H
    Folia Psychiatr Neurol Jpn; 1974 Jan; 28(1):1-10. PubMed ID: 4406943
    [No Abstract]   [Full Text] [Related]  

  • 14. [Amantadine therapy in parkinsonism].
    Pakkenberg H
    Ugeskr Laeger; 1973 Jan; 135(3):135-6. PubMed ID: 4685048
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J; Raymondeaud C; Piot C
    Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined treatment of Parkinson's disease with amantadine and L-dopa.
    Scotti G
    Lancet; 1970 Jun; 1(7661):1394-5. PubMed ID: 4194144
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
    Parkes JD; Baxter RC; Marsden CD; Rees JE
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amantadine and levodopa in the treatment of Parkinson's disease.
    Walker JE; Potvin A; Tourtellotte W; Albers J; Repa B; Henderson W; Snyder D
    Clin Pharmacol Ther; 1972; 13(1):28-36. PubMed ID: 4550321
    [No Abstract]   [Full Text] [Related]  

  • 19. Amantadine in Parkinson's disease. Review of more than two years' experience.
    Schwab RS; Poskanzer DC; England AC; Young RR
    JAMA; 1972 Nov; 222(7):792-5. PubMed ID: 4677928
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problematic long-term therapy of Parkinson's syndrome using amantadine salts].
    Diehl LW
    Med Welt; 1975 Nov; 26(48):2188-91. PubMed ID: 813085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.